Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flupirtine adjunct to opioids for cancer pain with neuropathic features
2011-001202-99Phase 2Completed
- Sponsor
- Relevare Pharmaceuticals
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cancer pain comparing Flupirtine + opioids with Placebo + opioids (2 arms). Primary endpoint: Primary efficacy endpoint. Started May 2011; status: completed.
02
Drugs
flupirtine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2011-001202-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001202-99.